|
Delayed
Toronto S.E.
17:53:20 20/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 32.15 CAD | +1.42% |
|
+5.48% | +29.43% |
| 06:01pm | Amgen and AstraZeneca celebrate positive Tezspire trial results in EoE | AN |
| 05:41pm | Amgen, AstraZeneca Say Tezspire Showed Improvement in Eosinophilic Esophagitis in Phase 3 Study | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +1.42% | +5.48% | +29.43% | - | - | 230B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
